Interventional Treatment of a Failing Pulmonic and Tricuspid Bioprosthesis in Hedinger Syndrome.
作者信息
Zengin Elvin, Sinning Christoph, Schäfer Ulrich
机构信息
Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany.
Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany.
出版信息
JACC Cardiovasc Interv. 2016 Aug 8;9(15):e145-6. doi: 10.1016/j.jcin.2016.07.015.
PMID:27491616
Abstract
摘要
相似文献
1
Interventional Treatment of a Failing Pulmonic and Tricuspid Bioprosthesis in Hedinger Syndrome.
JACC Cardiovasc Interv. 2016 Aug 8;9(15):e145-6. doi: 10.1016/j.jcin.2016.07.015.
2
Surgical management of carcinoid heart disease.
Chest. 1985 Nov;88(5):789-91. doi: 10.1378/chest.88.5.789.
3
Long-term durability of the pericardial valve.
Z Kardiol. 1986;75 Suppl 2:207-12.
4
Transannular pulmonary enlargement and bioprostheses for carcinoid disease.
Asian Cardiovasc Thorac Ann. 2009 Oct;17(5):510-2. doi: 10.1177/0218492309348628.
5
Use of a melody pulmonary valve in transcatheter valve-in-valve replacement for tricuspid valve bioprosthesis degeneration.
Tex Heart Inst J. 2014 Oct 1;41(5):511-3. doi: 10.14503/THIJ-13-3544. eCollection 2014 Oct.
6
Long-term prognosis following valvular heart surgery.
Cardiovasc Clin. 1986;16(2):437-505.
7
Haemodynamic evaluation of the Hancock bovine pericardial heart valve.
Z Kardiol. 1986;75 Suppl 2:241-4.
8
Tricuspid and pulmonary valve replacement in carcinoid heart disease: two case reports and a review of the literature.
J Heart Valve Dis. 1997 Mar;6(2):193-7.
9
Dysfunction of an On-X Heart Valve by Pannus.
J Heart Valve Dis. 2016 Sep;25(5):634-637.
10
Five-years actuarial analysis after heart valve replacement with the St. Jude medical prosthesis.
Z Kardiol. 1986;75 Suppl 2:282-5.
Zotero 插件